13G Filing: Acuta Capital Partners Files on Veracyte, Inc. (VCYT)

A new 13G filing has been submitted to the SEC by Acuta Capital Partners, in relation to the investor’s position in Veracyte Inc (NASDAQ:VCYT). The filing reveals the latest share ownership information of the investor, which stands at 1.71 million shares, as you can see embedded in the table below. These 13G filings can prove invaluable to investors, as they show the latest moves made by top investors in stocks which they are or were very bullish on, and in a timely fashion in most cases. You can find the latest such filing embedded below and on the following pages.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
ACUTA CAPITAL PARTNERS 1,716,000   1,716,000   1,716,000 6.2%

Page 1 of 7 SEC Filing

 

UNITED
STATES

SECURITIES AND EXCHANGE COMMISSION

Washington,
D.C. 20549

 

SCHEDULE
13G

 

Under
the Securities Exchange Act of 1934

(Amendment No. ________)*

 

VERACYTE
INC

(Name
of Issuer)

 

COMMON
STOCK

(Title
of Class of Securities)

 

92337F107

(CUSIP
Number)

 

ACUTA
CAPITAL PARTNERS LLC, 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002

(Name,
Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

FEBRUARY
12, 2016

(Date
of Event which Requires Filing of this Statement)

 

Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

[X]
Rule 13d-1(b)

 

[  ]
Rule 13d-1(c)

 

[  ]
Rule 13d-1(d)

 

*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect
to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided
in a prior cover page.

 

The
information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).

 

Follow Veracyte Inc. (NASDAQ:VCYT)